Role of viral BCI-2 mediated anti-apoptosis and-autophagy

点击翻译按钮获取中文摘要

DESCRIPTION (provided by applicant): Kaposi's sarcoma-associated herpesvirus (KSHV), an important human pathogen accounting for a large percentage of virally caused cancers worldwide, has evolved a variety of stratagems for evading host immune responses to establish a life-long persistent infection. Autophagy pathway consists of four distinct stages of autophagosome biogenesis-induction, vesicle nucleation, vesicle elongation, and vesicle maturation- by forming specific protein complexes. Our study has discovered a novel KSHV-mediated comprehensive inhibition of autophagy pathway where KSHV remarkably confers tight suppression of the autophagy by targeting each step of its signal transduction: by vBcl-2 in vesicle nucleation, by vFLIP in vesicle elongation, and by K7 in vesicle maturation. Specifically, the vBcl-2, vFLIP, and K7 not only possess anti- apoptotic activities but also serve as anti-autophagy molecules via their interactions with the Beclin1, the Atg3 E2 enzyme, and the Rubicon, respectively, which contributes to the establishment of viral persistency. This also indicates how important autophagy is as part of host immune responses against pathogens. Furthermore, we have recently developed an "infectious" KSHV bacterial artificial chromosome (BAC16) and TALEN- mediated genome editing that allows the efficient genetic manipulation of KSHV genome as well as host genome to study viral persistence and pathogenesis. Thus, the goal of this study is two-fold: firstly, to identify the specific mechanisms of how viral anti-autophagy proteins target and suppress autophagy- mediated host immunity and secondly, to test whether the suppression of autophagy-mediated host immunity is necessary for in vivo KSHV persistent infection. Despite previous extensive cell biology and biochemical studies, the detailed in vivo biological evidences of vBcl-2- and K7-mediated immune evasion for viral persistence are still elusive. In this proposal, we will attempt to define in vivo roles of the vBc-2 and K7 in vial persistence. Specifically, by utilizing in NOD/SCID IL2Rgamma-/- "humanized" mouse model, we will test whether the loss of vBcl-2 and/or K7 genes from the KSHV genome affects the establishment of viral persistence and how critical autophagy is as a host immune determinant to control the in vivo KSHV latency. This proposal is highly innovative and its successful outcome should significantly impact our understanding of KSHV biology.